| 24/11/17 | 10:23:52 | 24 Nov 2017 | | Holding(s) in Company | RNS |
| 21/11/17 | 07:00:09 | 21 Nov 2017 | | Grant of options | RNS |
| 20/11/17 | 07:00:06 | 20 Nov 2017 | | Change of Adviser | RNS |
| 16/10/17 | 10:00:01 | 16 Oct 2017 | | Holding(s) in Company | RNS |
| 13/10/17 | 10:00:01 | 13 Oct 2017 | | Director/PDMR Shareholding | RNS |
| 11/10/17 | 15:00:19 | 11 Oct 2017 | | Issue of Equity & PDMR Shareholding | RNS |
| 09/10/17 | 17:30:01 | 9 Oct 2017 | | Result of Placing & Subscription & Issue of Equity | RNS |
| 05/10/17 | 08:00:03 | 5 Oct 2017 | | Proposed Placing and Subscription | RNS |
| 02/10/17 | 08:00:05 | 2 Oct 2017 | | Traumakine Receives PIM Designation from MHRA | RNS |
| 11/09/17 | 16:19:37 | 11 Sept 2017 | | Directors Dealings | RNS |
| 06/09/17 | 08:00:03 | 6 Sept 2017 | | Interim Results | RNS |
| 04/09/17 | 08:00:05 | 4 Sept 2017 | | FDA advises Faron to proceed directly to BLA | RNS |
| 04/08/17 | 08:00:03 | 4 Aug 2017 | | Update on INTEREST Phase III Study from IDMC | RNS |
| 28/07/17 | 10:34:11 | 28 Jul 2017 | | Holding(s) in Company | RNS |
| 10/07/17 | 17:51:44 | 10 Jul 2017 | | Holding(s) in Company | RNS |
| 10/07/17 | 08:00:12 | 10 Jul 2017 | | Notice of Results | RNS |
| 16/06/17 | 15:43:55 | 16 Jun 2017 | | Director/PDMR Shareholding | RNS |
| 01/06/17 | 08:00:03 | 1 Jun 2017 | | Exercise of Warrants and Options | RNS |
| 30/05/17 | 15:06:49 | 30 May 2017 | | Holdings in Company | RNS |
| 22/05/17 | 12:31:06 | 22 May 2017 | | Director/PDMR Shareholding | RNS |
| 22/05/17 | 08:00:11 | 22 May 2017 | | Director/PDMR Shareholding | RNS |
| 18/05/17 | 10:20:25 | 18 May 2017 | | Director/PDMR Shareholding | RNS |
| 16/05/17 | 13:00:03 | 16 May 2017 | | Result of AGM | RNS |
| 08/05/17 | 17:40:44 | 8 May 2017 | | Second Price Monitoring Extn | RNS |
| 08/05/17 | 17:35:28 | 8 May 2017 | | Price Monitoring Extension | RNS |
| 08/05/17 | 08:00:09 | 8 May 2017 | | Update on INTEREST Phase III Study from IDMC | RNS |
| 27/04/17 | 18:57:50 | 27 Apr 2017 | | Exercise of Warrants | RNS |
| 26/04/17 | 13:32:22 | 26 Apr 2017 | | Director's dealings | RNS |
| 21/04/17 | 18:56:52 | 21 Apr 2017 | | Director/PDMR Shareholding | RNS |
| 19/04/17 | 08:00:10 | 19 Apr 2017 | | Notice of Annual General Meeting | RNS |
| 19/04/17 | 08:00:10 | 19 Apr 2017 | | Proposed Board Changes | RNS |
| 18/04/17 | 17:17:08 | 18 Apr 2017 | | Purchase of Shares | RNS |
| 18/04/17 | 08:00:12 | 18 Apr 2017 | | Collaboration with Birmingham University | RNS |
| 13/04/17 | 14:43:30 | 13 Apr 2017 | | Purchase of Shares | RNS |
| 04/04/17 | 08:00:11 | 4 Apr 2017 | | Director/PDMR Shareholding | RNS |
| 29/03/17 | 08:00:18 | 29 Mar 2017 | | Final Results 2016 | RNS |
| 27/03/17 | 10:23:11 | 27 Mar 2017 | | Holding(s) in Company | RNS |
| 21/03/17 | 11:05:20 | 21 Mar 2017 | | Second Price Monitoring Extn | RNS |
| 21/03/17 | 11:00:13 | 21 Mar 2017 | | Price Monitoring Extension | RNS |
| 07/03/17 | 10:54:25 | 7 Mar 2017 | | Holding(s) in Company | RNS |
| 07/03/17 | 07:00:13 | 7 Mar 2017 | | Notice of Full Year Results | RNS |
| 03/03/17 | 11:02:02 | 3 Mar 2017 | | Holding(s) in Company | RNS |
| 01/03/17 | 14:05:32 | 1 Mar 2017 | | Second Price Monitoring Extn | RNS |
| 01/03/17 | 14:00:28 | 1 Mar 2017 | | Price Monitoring Extension | RNS |
| 01/03/17 | 11:35:38 | 1 Mar 2017 | | Result of Placing & Subscription & Issue of Equity | RNS |
| 28/02/17 | 07:00:17 | 28 Feb 2017 | | Proposed Placing and Subscription | RNS |
| 20/02/17 | 07:00:10 | 20 Feb 2017 | | First Patient Recruited in Phase II RAAA Study | RNS |
| 09/02/17 | 07:00:08 | 9 Feb 2017 | | Faron update for 2017 | RNS |
| 09/12/16 | 13:05:02 | 9 Dec 2016 | | Notification of Major Interest in Shares | RNS |
| 09/12/16 | 13:00:01 | 9 Dec 2016 | | Notification of Major Interest in Shares | RNS |
